Learn more about whether BioMarin Pharmaceutical Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today presented promising ...

Learn more about whether Halozyme Therapeutics, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Presenters at the AAO 2025 meeting outlined a future for retinal care that reduces patient burden by reconsidering treatment delivery methods.

Researchers at TU Wien have developed numerical models to simulate the movement of fluids in porous materials.

Panelists discuss how SC delivery enhances patient convenience and health care efficiency in NSCLC treatment.

Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...

WACO, Texas (KWTX) - AT&T and Human-I-T gave away 65 laptops to Waco students Wednesday afternoon in partnership with Transformation Waco. The laptop distribution event for pre-selected students was ...

A conservationist dubbed the “human swan” is expected to give evidence in person at a fatal accident inquiry into a fatal mid-air paramotor collision she was involved in, a hearing has been told. Dan ...